Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia.

Authors:
Issa H; Swart LE; Rasouli M; Ashtiani M; Nakjang S and 5 more

Journal:
Leukemia

Publication Year: 2023

DOI:
10.1038/s41375-023-01854-8

PMCID:
PMC10079536

PMID:
36823395

Journal Information

Full Title: Leukemia

Abbreviation: Leukemia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability rna next-generation atac and cut&run sequencing data have been submitted to the gene expression omnibus (accession number gse217113).; additional rna-seq samples were previously deposited in the gene expression omnibus (accession number gse54478). data availability rna next-generation atac and cut&run sequencing data have been submitted to the gene expression omnibus (accession number gse217113"

Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"The authors would like to thank Constanze Bonifer for carefully reading the manuscript, Cor Seinen (UMC Utrecht) for performing the cryoEM, Shalini Sankar for testing siRE in MV4-11 cells, and the staff of the Comparative Biology Centre (CBC) at Newcastle University for supporting the in vivo experiments. OH is supported by grants from Cancer Research UK (C27943/A23389), Bloodwise (15005), Kay Kendall Leukemia Fund (KKL1142), the North of England Children’s Cancer Fund and KIKA (329). HI was supported by an AKEB Aga Khan fellowship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025